Our findings not only identified CD147 as a novel receptor for TFF3 but also uncovered a novel mechanism for the contribution of the TFF3-CD147 ligand-receptor system to mucosal restitution and CRC progression. This evidence concerns the gene TFF3 and colorectal carcinoma.